Castro Valley, CA, United States of America

Miles C Scotcher


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Miles C. Scotcher: Innovator in Botulinum Toxin Detection**

Introduction

Miles C. Scotcher, an accomplished inventor based in Castro Valley, California, has made significant contributions to the field of biotechnology. With a noteworthy portfolio of three patents, Scotcher's work focuses on developing high-affinity monoclonal antibodies for botulinum toxin type B. These innovations provide valuable tools for detecting this potent toxin in various samples.

Latest Patents

Scotcher's latest patents include a groundbreaking description of high-affinity antibodies capable of binding to specific epitopes of botulinum toxin type B (BoNT/B). These antibodies are pivotal for creating kits that facilitate the detection of BoNT/B in biological samples. Such advancements not only enhance our understanding of toxin detection but also offer practical applications in medical and safety fields.

Career Highlights

Currently, Miles C. Scotcher is affiliated with the United States of America, as represented by the Secretary of Agriculture. His role brings him into the forefront of research and development, where he applies his innovative ideas to address critical health and safety challenges. His work exemplifies the integration of scientific research with practical applications, particularly in the field of biotechnology.

Collaborations

Throughout his career, Scotcher has collaborated with notable colleagues, including Larry H. Stanker and Luisa W. Cheng. Their collective expertise has fostered an environment of innovation and discovery, leading to the advancement of crucial research in the detection of botulinum toxin. Such collaborations underscore the importance of teamwork in achieving significant scientific breakthroughs.

Conclusion

Miles C. Scotcher's dedication to innovation and his focus on developing high-affinity monoclonal antibodies for botulinum toxin type B mark him as a key figure in the field of biotechnology. His contributions not only enhance detection methods but also pave the way for future research and applications that can impact public health and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…